Grantham, Mayo, Van Otterloo & Co (GMO)’s Inogen INGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-64,300	Closed	-$1.86M	–	843
2020 Q3	$1.86M	Buy	64,300 +3,000	+5%	+$94.2K	0.01%	425
2020 Q2	$2.18M	Buy	+61,300	New	+$2.58M	0.02%	396

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s INGN Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Inogen (INGN) in Q4 2020, closing a stake of 64,300 shares — an estimated $1.86M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in INGN in Q2 2020 and held it in 2 quarters. The position peaked at $2.18M in Q2 2020. 161 funds tracked by Wall St. Rank hold INGN as of Q4 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Inogen position as of Q4 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 64,300 Inogen shares in Q4 2020, an estimated $1.86M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Inogen in Q2 2020 and held it in 2 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Inogen position peaked at $2.18M in Q2 2020.
161 funds tracked by Wall St. Rank held Inogen as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.